Searched for
NANDINI PIRAMAL
West Asia conflict triggers energy shock, tests Asia’s growth resilienceAsia faces economic challenges as a West Asia conflict disrupts energy markets. This shock impacts inflation and growth across the region. ...- Nandini Piramal warns prolonged West Asia war may raise input costsGeopolitical tensions in West Asia are manageable now. However, a prolonged US-Israel war against Iran could raise costs for petrochemical-...
- Piramal Healthcare targets $2 bn revenue by FY30, to focus on organic expansion: Chairperson Nandini PiramalPiramal Healthcare prioritizes organic growth for the next 4-5 years. The company will explore licensing and product acquisitions in comple...
- Piramal Pharma deploying USD 85 mn capex this fiscal: Nandini PiramalPiramal Pharma is investing USD 85 million this fiscal for initiatives like capacity expansion and maintenance. They have already used USD ...
- Piramal Pharma targets to double revenue in 5 yearsPiramal Pharma aims to achieve $2 billion in annual revenue with a 25% operating margin by fiscal 2030, driven by its CDMO business. The co...
- In 3-5 years, Piramal Pharma can see 22- 25% EBITDA growth margins: Nandini PiramalNandini Piramal projects early teens revenue growth for FY25 and 22-25% EBITDA growth margins in 3-5 years. Revenue increase drives margin ...
- After a tough year, Piramal Pharma hopes to regain vigour in 2nd halfPiramal Pharma chairperson Nandini Piramal in an interview to ET said the company is aiming for mid-teen revenue growth and a meaningful im...
- Pickup in contract manufacturing biz set to drive growth: Piramal Pharma"During the year (FY23), the customer decision-making got delayed due to macro-economic environment and pipeline prioritisation based on li...
- Piramal bets on babycare, aims to double sales in 2-3 yearsTo take on large rivals in the baby care segment such as Johnson & Johnson, HUL, Wipro and others, the company is relying on both offline a...
- Piramal board okays demerger of pharma, financial services operationsThe amalgamation of PHL Fininvest Private Limited with PEL will create a listed non-banking financial services (NBFC) entity. The merged ho...
- Piramal Enterprises to cover vaccination costs for employees taking jabs in IndiaThe company will absorb the cost of Covid-19 vaccination for all its employees and their immediate family members that are eligible and cho...
- Piramal Pharma enters feminine intimate care segmentThe company has launched 'i-feel Gentle Intimate Wash' which would be initially available in the West Bengal market and on all leading e-co...
- Plan to list pharma business in near-to-medium term: Nandini Piramal"We have a very differentiated business and are a very global business."
- Sell Piramal Enterprises, target Rs 2,260: Kunal BothraSell Piramal Enterprises Ltd. at a price target of Rs 2260.0 and a stop loss at Rs 2405 from the entry point.
- Buy Piramal Enterprises, target Rs 3,030: Kunal BothraBuy Piramal Enterprises Ltd. at a price target of Rs 3030.0 and a stop loss at Rs 2870 from entry point.
- Buy Piramal Enterprises, target Rs 3,080: Manas JaiswalBuy Piramal Enterprises at a price target of Rs 3,080 and a stop loss at Rs 2,879 from entry point.
- Piramal Enterprises to acquire four Pfizer brands for Rs 110 crorePiramal Enterprises is acquiring four brands of US drug maker Pfizer for Rs 110 crore, the third such acquisition by the Mumbai-based compa...
- Nandini Piramal overhauls HR as group takes wing into newer territoriesPiramal Group is the latest Indian conglomerate to revamp its human resource and leadership planning strategy to meet the needs of a highly...
- Ajay Piramal ropes in family, friends; to foray into home security solutions, defence and drug discoveryPiramal wants the group to enter the security systems business and play a role in creating new drugs from scratch.
- GeNext promoters step into company boardroomsPiramal Healthcare on Wednesday inducted Nandini Piramal, daughter of promoters Ajay and Swati Piramal, on to the company board, as part of...
Load More
